1. Home
  2. FSUN vs ESPR Comparison

FSUN vs ESPR Comparison

Compare FSUN & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$38.36

Market Cap

966.0M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$4.04

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
ESPR
Founded
1892
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.0M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
FSUN
ESPR
Price
$38.36
$4.04
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$46.33
$6.67
AVG Volume (30 Days)
138.6K
5.3M
Earning Date
01-26-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
3.52
N/A
EPS
3.16
N/A
Revenue
$384,497,000.00
$303,802,000.00
Revenue This Year
$19.09
$26.11
Revenue Next Year
$62.50
N/A
P/E Ratio
$12.14
N/A
Revenue Growth
10.48
2.83
52 Week Low
$29.95
$0.69
52 Week High
$45.32
$4.13

Technical Indicators

Market Signals
Indicator
FSUN
ESPR
Relative Strength Index (RSI) 61.72 61.22
Support Level $37.13 $3.87
Resistance Level $40.07 $4.13
Average True Range (ATR) 1.06 0.20
MACD 0.10 -0.02
Stochastic Oscillator 64.32 79.00

Price Performance

Historical Comparison
FSUN
ESPR

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: